Skip to main content
Caplight Logo









Axiles Bionics

Axiles Bionics

Private
BrusselsHealthcare & Life Scienceshttps://www.axilesbionics.com/

Last Round

Series A

Jun 24, 2025

Total Funding Raised

$15.18M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Axiles Bionics is a health-tech company that develops AI-driven, robotic ankle-foot prostheses designed to restore a natural gait for lower-limb amputees.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Industrial Robotics, Health IoT

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

bionic footrobotic prosthesisankle-foot prosthesisAI prosthesismedical devicessmart prosthesisprosthetics as a servicemicroprocessor footmedtechmedical AIbionic legwearable roboticsnatural gaitassistive technologyon-device AIhealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axiles Bionics Comparables

Compare Axiles Bionics with similar companies based on industry and business-model similarity.

Axiles Bionics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Embla Medical hf
81%
Proteor
78%
Otto Bock
76%

Axiles Bionics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 24, 2025
GrantOct 5, 2022
GrantOct 21, 2021
GrantSep 17, 2020
Series ASep 18, 2019

Key People

Founding team and executive leadership

Jacques Langhendries

Co-Founder, Investor, Member of Board of Directors, CFO

Founding Team

Felipe Gomez

Chief Technology Officer

Executive Team

Axiles Bionics Investors

Notable investors and investment history

Axiles Bionics investors
InvestorRounds
European Innovation Council FundGrant
PE Capital GroupSeries A
European CommissionGrant
finance&invest.brusselsSeries A
InnovirisGrant
EIC FundSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Grew 21% QoQ, from 29 to 35 employees.

  • Jul 27, 2026

    Open roles increased to 36, 106% of headcount.

Axiles Bionics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Axiles Bionics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Axiles Bionics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrussels
Employee Range35
Year Founded2019
Last FundingJun 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?